Gabriela Hobbs, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Abbvie
    Topic: 
    myelofibrosis
    Date added: 
    01/23/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Novartis
    Topic: 
    CML
    Date added: 
    01/23/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Pfizer
    Topic: 
    CML
    Date added: 
    01/23/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    BMS
    Topic: 
    myelofibrosis
    Date added: 
    01/23/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Pharmaxis
    Topic: 
    myelofibrosis
    Date added: 
    01/23/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Cogent
    Topic: 
    Mastocytosis
    Date added: 
    01/23/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Morphosys
    Topic: 
    myelofibrosis
    Date added: 
    01/23/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Incyte
    Topic: 
    Myelofibrosis
    Date added: 
    01/23/2023
Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice